单向瓣膜分流术治疗终末期肺动脉高压的早期经验
本研究回顾性分析了5例青少年及成人特发性肺动脉高压患者,采用新型单向瓣膜分流术(UVS)治疗。所有患者基线均有超体循环肺动脉压、右心室功能差及WHO功能IV级症状,术后随访3-33个月全部存活且无需移植。UVS可能为不适合肺移植的终末期IPAH患者提供替代方案。
要点
- UVS通过单向瓣膜避免双向分流并发症,实现右心室减压并保留上半身氧合。
- 5例患者术后随访3-33个月全部存活且未行肺移植。
- UVS可能为青少年和年轻成人IPAH患者提供肺移植的替代选择。
核心结论
- 单向瓣膜分流术(UVS)可能为青少年和年轻成人特发性肺动脉高压(IPAH)患者提供肺移植的替代方案。
研究设计与样本
- 单中心回顾性研究,纳入2016年11月1日至2019年5月1日在哥伦比亚大学医学中心-纽约长老会医院接受UVS的5例患者(4例女性,年龄12-22岁)。
主要发现
- 所有患者基线均有超体循环肺动脉压、右心室功能差和WHO功能IV级症状。
- 所有患者至最新随访(范围3-33个月;中位6±11个月)均存活且未行移植。
关键数值与推荐
- 纳入患者年龄12-22岁,均有超体循环肺动脉压、右心室功能差和WHO功能IV级症状。
- 随访时间范围3-33个月,中位6±11个月。
临床怎么用
- 对于青少年和年轻成人终末期IPAH伴超体循环肺动脉压和右心室功能差者,UVS可考虑作为肺移植的替代或过渡方案。
局限性
- 单中心回顾性研究,样本量小(5例),随访时间有限,需更长期随访确定UVS对右心室单向卸载的最终影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Despite advances in treatment of idiopathic pulmonary arterial hypertension (IPAH), there remains no medical cure, and patients can experience disease progression leading to right heart failure, progressive exercise intolerance, and death. The reversed Potts shunt (left pulmonary artery to descending aorta) was reintroduced for treatment of end-stage IPAH to permit decompression of the suprasystemic right ventricle by right to left shunting, with preservation of upper body oxygenation. The shunt has the potential to delay the need for lung transplantation and offer a treatment for those who are transplant ineligible. To optimize shunt design and avoid the potential complications of bidirectional shunting, we developed a novel approach using a unidirectional-valved shunt (UVS) in patients with IPAH with suprasystemic pulmonary arterial pressure and poor right ventricular function. METHODS: A single-center retrospective review was performed of UVS cases done at Columbia University Medical Center-New York Presbyterian between November 1, 2016, and May 1, 2019. RESULTS: Five patients (4 female; ages 12-22 years) underwent UVS. All had suprasystemic pulmonary arterial pressure, poor right ventricular function, and World Health Organization functional class IV symptoms at baseline. All patients are alive and transplant-free at latest follow-up (range 3-33 months; median 6 ± 11 months). CONCLUSIONS: The UVS may offer an alternative solution to lung transplantation in adolescents and young adults with IPAH. Longer-term follow-up is needed to determine the ultimate impact of unidirectional unloading of the right ventricle in these patients and to determine whether the UVS will enable a broader approach to the treatment of patients with IPAH.
引用
- Rosenzweig EB, Ankola A, Krishnan U, et al. A novel unidirectional-valved shunt approach for end-stage pulmonary arterial hypertension: Early experience in adolescents and adults. J Thorac Cardiovasc Surg. 2019. PMID: 31839227. doi:10.1016/j.jtcvs.2019.10.149
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。